Spruce Biosciences, Inc. (NASDAQ:SPRB – Get Free Report) has been given a consensus recommendation of “Hold” by the eight ratings firms that are covering the company, MarketBeat Ratings reports. Six investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 1 year price […]
Related Keywords
Leerink Partnrs , Vanguard Group Inc , Armistice Capital , Capital Management , Spruce Biosciences Inc , Alyeska Investment Group , Nasdaq , Holdingsas Novo , Spruce Biosciences , Get Free Report , Marketbeat Ratings , Get Free , Spruce Biosciences Daily , Nasdaq Sprb , Isprb , Medical , Ratings , Consensus ,
comparemela.com © 2020. All Rights Reserved.